It is characterized by elevated parathyroid hormone (PTH) levels with normal albumin-corrected calcium, in the absence of secondary causes of hyperparathyroidism, such as vitamin D deficiency, medications influencing calcium metabolism, and chronic kidney disease. This evidence concerns the gene PTH and chronic kidney disease.